Compare SOPH & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOPH | PAYS |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.3M | 485.8M |
| IPO Year | 2021 | 2020 |
| Metric | SOPH | PAYS |
|---|---|---|
| Price | $6.85 | $9.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.50 | ★ $9.42 |
| AVG Volume (30 Days) | 294.5K | ★ 468.5K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.71 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $24,120,434.00 |
| Revenue This Year | $23.09 | $33.83 |
| Revenue Next Year | $19.57 | $14.89 |
| P/E Ratio | ★ N/A | $103.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.97 | $3.08 |
| 52 Week High | $6.77 | $9.49 |
| Indicator | SOPH | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The The company generates revenues from pharma card programs through card program management fees, transaction claim processing fees, interchange fees, customer service fees, other billable service fees and settlement income and other revenues are generated through cardholder fees, interchange fees, program management fees, load fees and breakage.